PHARVARIS NV - EXPECTS RAPIDE-3 DATA ANNOUNCEMENT IN Q4 2025
PHARVARIS NV - PLANS NDA SUBMISSION TO FDA IN H1 2026
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.